Supramolecular “Trojan Horse” for Nuclear Delivery of Dual Anticancer Drugs-Reference-Cited by-同舟云学术

Supramolecular “Trojan Horse” for Nuclear Delivery of Dual Anticancer Drugs

Published:2017-02-14 Issue:8 Volume:139 Page:2876-2879
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Cai Yanbin¹,Shen Haosheng¹,Zhan Jie¹,Lin Mingliang¹,Dai Liuhan¹,Ren Chunhua²,Shi Yang¹,Liu Jianfeng²,Gao Jie¹^ORCID,Yang Zhimou¹^ORCID

Affiliation:

1. State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, and Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University, Tianjin 300071, P. R. China

2. Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin 300192, P. R. China

Funder

Ministry of Education of the People's Republic of China

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/jacs.6b12322

Reference36 articles.

1. Cancer drug resistance: an evolving paradigm